The initial signal for triggering human parturition might be fetal but of trophoblastic origin. Concomitantly, this KEY WORDS Human parturition, placenta, uterus, extracellular matrix, signaling factors, contractility the act of "bringing a child into the world is one of the essential keys to life and to the survival of the species, we cannot help but be amazed even today by the fact that most of the physiological mechanisms of human parturition remain to be elucidated. Giving birth is not a trivial act. Indeed, the pathologies associated with it, whose etiologies remain poorly understood, can expose both mother and child to varying types of grave complications. Premature birth, for instance, is an important unsolved health problem.
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One of the reasons why the processes of human parturition remain to some extent enigmatic is that results of research utilizing animal models, which can then be transposed to humans, are, in fact, very rare. Indeed, there exists extreme species diversity, especially in endocrine balance, which conditions the maintenance of gestation. In women, one particularity would appear to lie in the absence of a correlation between the evolution of available parameters, such as the plasma level of steroid hormones or of many other effectors of uterine activity, and the onset of labor. In this respect, it is only recently that we have became aware of the specificity of the human species, as current data reveal a multitude of pertinent factors, be they genetic, hormonal or environmental. This complexity, also present in the mechanisms of action of these factors, has for the moment escaped any simplifying principle, whatever the level of analysis of the biological systems which are targets in the maternal-fetal system.
Nevertheless, although experimentation is limited by considerations of an ethical or practical nature, the availability of molecular biological techniques and of selective pharmacological tools, and the development of human cell models in the same way as those enabling better understanding of the different components of uterine contraction, should facilitate an approach to this intricacy.
The initial question raised is that of the hormonal determination of parturition. The second, FERRY, upon which we will place special emphasis, concerns the molecular mechanisms which, in the Of all the organs, it is the placenta which has the greatest species specificity in terms of its morphological, structural and functional characteristics. 6 Indeed, there exist several ways of optimizing the fetomaternal exchanges through the placenta. We might thus raise the question as to whether the species diversity noted in the mechanisms of the onset of parturition might not, in part, be linked to the mode of placentation (the human placenta is of a hemochorial type).
At the fetomaternal interface, structures other than the villous trophoblast are able to express a certain number of biologically active substances and their receptors: extravillous and invasive trophoblast, amniotic and decidual cells, and immune cells (macrophages, lymphocytes). The potentialities of expression of myometrial cells are also being examined at present. It is within the intervillous blood space, the circulation which is specific to the human fetomaternal interface, that some of these substances which control both the development of the fetus and uterine activity are found at high concentrations at the end of pregnancy.
FERRIC, each substance in the control of uterine activity is difficult to evaluate. This situation is accentuated at the site of placental insertion, where interactions between fetal and maternal cells are established which are both subtle and evolutive. 8 Indeed, it is in the human species that the invasion of uterine tissue by trophoblast cells is the most extensive, colonizing the wall of the spiral uterine arteries and reaching the inner layer of the myometrium.
Although we are uncertain whether it was chance alone which determined the diversity of the placental structure and that of the fetomaternal interface according to the species, these phenomena which, in the human species are superimposed upon classical endocrine activity, could be one of the signs of evolution. z8 It is now known that it is a family of isoforms, the PLC-[3, which is implicated in the activation of the receptors to seven transmembrane domains coupled to G proteins. Three isoforms, 131, 132 and 133, are involved in the contraction effect of oxytocin in the human myometrium. Another family of isoforms, PLC-y, whose mode of activation differes from that of PLC-13, also leads to mobilization of Cae+i. In the human myometrium, the EGF receptor, which possesses tyrosine kinase activity, stimulates the PLC-y via phosphoryla- In addition, oxytocin and very likely the CRH and endothelins stimulate phospholipase A z activity, leading to synthesis of endogenous prostaglandins in the human gravid myometrium. The latter, in turn, stimulate PLC-13, thereby amplifying their direct effects upon this enzymatic pathway.
In the course of the third trimester of pregnancy, a phenomenon ofheterologous desensitization to the relaxing agents: 132-adrenergic and prostaglandins, activators of adenylyl cyclase, has been revealed in the human myometrium. 31, 32 This mechanism of desensitization also has bearing on activation of adenyly cyclase by the CRH, in the human term myometrium. Like the catecholamines and prostaglandins, the alteration in the coupling of certain of the CRH receptors to the catalytic component of adenylyl cyclase via a Gs protein has been observed. 33 In This hormone-sensitive PDE4 activity is the point of impact of pharmacologic agents with myorelaxing and anti-inflammatory properties. 36 The nitric oxide (NO) pathway could be a link with the mechanisms responsible for maintenance of the quiescent state in the uterus during pregnancy. Indeed, its use in the treatment of threatened premature birth has been proposed. The NO synthase system, which is very active in the gravid human uterus, decreases at the time of labor. However, the role of cGMP in myometrial relaxation induced by NO has not been entirely elucidated, a7 Other substances classically identified as growth factors (IGFs, EGF) and gonadotropins (hCG), whose receptors have recently been revealed in the human myometrium, also appear to be regulators of contraction. 8, 9 This action would be due to stimulation of eicosano'l'd production and/or to the fact that the multiple signals use common or interacting signaling pathways. Among various kinases, which play a role in the signaling cascade, the role of MAP kinase and tyrosine kinases needs to be clarified.
In the myometrium as in the cervix, the steroid hormone receptors exert their pleiotropic effects by modulating the transcription of a number of target genes which code for the structural and contractile proteins, for enzymatic proteins In general, the effects of progesterone are directly opposite those of the estrogens, which induce the synthesis of signals and of proteins which intervene in contraction. Nevertheless, this is not always the case: the presence of progesterone is, in fact, required during the induction of the synthesis of certain ionic channels by 1713-estradiol. Considering that progesterone favors the expression of immunosuppressive cytokines during gestation, it remains to clarify what happens with the Th2/Thl cytokine balance in the different cell populations of the uterus at time of parturition.
There unquestionably exist, in the myometriurn, rapid non-genomic effects of steroid hormones which to a certain extent interfere via second messengers with the genomic effects. Although the notion of membrane receptors of steroid hormones remains subject to controversy, progesterone decreases and 17[3-estradiol increases the fluidity of the plasma membranes.These modifications could both influence the organization and function of the membrane proteins and modulate the flexibility necessary for morphological changes which the smooth uterine fiber undergoes during the contraction-relaxation cycle. Hyperpolarizing progesterone, by inhibiting the VOC type L channels responsible for the entry of calcium into the myometrial cell and, consequently, for MLCK activity,
